Monoclonal Lym-1 antibody-dependent lysis of B-lymphoblastoid tumor targets by human complement and cytokine-exposed mononuclear and neutrophilic polymorphonuclear leukocytes

Blood

Volumn 87, Issue 12, 1996, Pages 5171-5178

  Ottonello, Luciano ^a   Morone, Paola ^a   Dapino, Patrizia ^a   Dallegri, Franco ^a,b  

^a UNIVERSITY OF GENOA   (Italy)

^b UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTAXIN; COMPLEMENT; COMPLEMENT COMPONENT C5A; CYTOKINE; FORMYLMETHIONYLLEUCYLPHENYLALANINE; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HLA DR ANTIGEN; IMMUNOGLOBULIN G2A; INTERLEUKIN 2; INTERLEUKIN 8; MONOCLONAL ANTIBODY; SOMATOMEDIN C; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; ARTICLE; CROSS REACTION; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LYMPHOBLASTOID CELL; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL;

EID: 0029890986     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.12.5171.bloodjournal87125171     Document Type: Article

References (30)

1. Epstein AL, Mader RJ, Winter JN, Stathopoulos E, Chen FM, Parker JW, Taylor CR: Two new monoclonal antibodies, Lym-1 and Lym-2, reactive with human B-lymphocytes and derived tumors, with immunodiagnostic and immunotherapeutic potential. Cancer Res 47:830, 1987
2. Epstein AL, Zimmer AM, Spies SM: Radioimmunodetection of human B-cell lymphomas with a radiolabeled tumor specific monoclonal antibody, Lym-1, in Cavalli F, Bonadonna G, Rozencweig M (eds): Malignant Lymphomas and Hodgkin Disease: Experimental and Therapeutic Advances. Boston, MA, Martinus Nijhoff, 1985, p 569
3. Hu E, Epstein AL, Naeve GS, Gill I, Martin S, Sherrod A, Nichols P, Chen D, Mazumder A, Levine AM: A phase 1a clinical trial of Lym-1 monoclonal antibody serotherapy in patients with refractory B cell malignancies. Hematol Oncol 7:155, 1989
4. Gill I, Agah R, Hu E, Mazumder A: Synergistic antitumor effects of interleukin 2 and the monoclonal Lym-1 against human Burkitt lymphoma cells in vitro and in vivo. Cancer Res 49:5377, 1989
5. Biddle WC, Pancook J, Goldrosen M, Han T, Foon KA, Vaickus L: Antibody-dependent, cell-mediated cytotoxicity by an anti-class II murine monoclonal antibody: Effect of recombinant interleukin-2 on human effector cell lysis of human B-cell tumors. Cancer Res 50:2991, 1990
6. Vaickus L, Biddle W, Cemerlic D, Foon KA: Interferon gamma augments Lym-1-dependent, granulocyte-mediated tumor cell lysis. Blood 75:2408, 1990
7. Cemerlic D, Dadey B, Han T, Vaickus L: Cytokine influence on killing of fresh chronic lymphocytic leukemia cells by human leukocytes. Blood 77:2707, 1991
8. Aggarwal BB, Pocsik E: Cytokines: From clone to clinic. Arch Biochem Biophys 292:335, 1992
9. Fu YK, Arkins S, Wang BS, Kelley KW: A novel role of growth hormone and insulin-like growth factor-1. Priming neutrophils for superoxide anion secretion. J Immunol 146:1602, 1991
10. Djen JY, Liu JH, Wei S, Rui H, Pearson CA, Leonard WJ, Blanchard DK: Function associated with the IL-2 receptor-B on human neutrophils. Mechanism of activation of antifungal activity against Candida albicans by IL-2. J Immunol 150:960, 1993
11. Dinarello CA: Role of interleukin-1 and tumor necrosis factor in systemic responses to infection and inflammation, in Gallin JI, Goldstein IM, Snyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1992, p 211
12. Gerard C, Gerard NP: The pro-inflammatory seven-transmembrane segment receptors of the leukocytes. Curr Opinion Immunol 6:140, 1994
13. Dallegri F, Patrone F, Frumento G, Ballestrero A, Sacchetti C: Down-regulation of K cell activity by neutrophils. Blood 65:571, 1985
14. Dankberg F, Persidsky M: A test of granulocyte membrane integrity and phagocytic function. Cryobiology 13:430, 1976
15. Safrit JT, Bonavida B: Hierarchy of in vitro and resistance of tumor cells to cytotoxic effector cells, cytokines, drugs and toxins. Cancer Immunol Immunother 34:321, 1992
16. Cairo MS, Wang J, Plunkett JM, Norvitch M, Van de Ven C: GM-CSF and IL-3 significantly enhance the antibody-dependent cytotoxicity (ADCC) of the Lym-1 antibody against B-cell malignancy. Proc Am Assoc Cancer Res 32:261, 1991 (abstr)
17. Dallegri F, Patrone F, Frumento G, Sacchetti C: Antibody-dependent killing of tumor cells by polymorphonuclear leukocytes. Involvement of oxidative and nonoxidative mechanisms. J Natl Cancer Inst 73:331, 1984
18. Kurshner BH, Cheung NKV: GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma. Blood 75:1936, 1989
19. Baldwin GC, Chung GY, Kaslander C, Esmail T, Reisfeld RA, Golde DW: Colony-stimulating factor enhancement of myeloid effector cell cytotoxicity towards neuroectodermal tumour cells. Br J Haematol 83:545, 1993
20. Ragnhammar P, Frödin JE, Trotta PP, Mellstedt H: Cytotoxicity of white blood cells activated by granulocyte-colony-stimulating factor, granulocyte/macrophage-colony-stimulating factor and macrophage-colony-stimulating factor against tumor cells in the presence of various monoclonal antibodies. Cancer Immunol Immunother 39:254, 1994
21. Harmenberg J, Höglund M, Hellström-Lindberg E: G- and GM-CSF in oncology and oncological haematology. Eur J Haematol 52:1, 1994
22. Vadhan-Raj S, Cordon-Cardo C, Carswell E, Mintzer D, Dantis L, Duteau C, Templeton MA, Oettgen HF, Old LJ, Houghton AN: Phase I trial of a mouse monoclonal antibody against GD3 ganglioside in patients with melanoma: Induction of inflammatory responses at tumor sites. J Clin Oncol 6:1636, 1988
23. Grossbard ML, Press OW, Appelbaum FR, Bernstein ID, Nadler LM: Monoclonal antibody-based therapies of leukemia and lymphoma. Blood 80:863, 1992
24. Schell-Frederick E, Tepass T, Lorscheidt G, Pfreundsche M, Schaadt M, Diedl V: Effects of recombinant tumor necrosis factor (rhuTNFα) on human neutrophils and monocytes: In vitro, ex vivo and in vivo. Eur J Haematol 43:286, 1989
25. Heslop HE, Gottlieb DJ, Bianchi ACM, Maerger A, Prentice HHG, Metha AB, Hoffbrand AV, Brenner MK: In vivo induction of gamma interferon and tumor necrosis factor by interleukin-2 infusion following intensive chemotherapy or autologous bone marrow transplantation for hematologic malignancies. Blood 77:1374, 1989
26. Styrt B: The role of phagocytes in non-infectious diseases, in Klempner MS, Styrt B, Ho J (eds): Phagocytes and Diseases. Dordrecht, The Netherlands, Kluwer, 1989, p 145
27. Charak BS, Agah R, Mazumder A: Granulocyte-macrophage colony-stimulating factor-induced antibody-dependent cellular cytotoxicity in bone marrow macrophages: Application in bone marrow transplantation. Blood 81:3474, 1993
28. Golde DW, Baldwin GC: Myeloid growth factors, in Gallin JI, Goldstein IM, Suyderman R (eds): Inflammation: Basic Principles and Clinical Correlates. New York, NY, Raven, 1992, p 291
29. Brach MA, de Vos S, Gruss HJ, Herrmann F: Prolongation of survival of human polymorphonuclear neutrophils by granulocyte-macrophage colony-stimulating factor is caused by inhibition of programmed cell death. Blood 80:2920, 1992
30. Ragnhammar P, Fagerberg J, Frodin JE, Hjelm AL, Lindemalm C, Magnusson I, Masucci G, Mellstedt H: Effect of monoclonal antibody 17-1A and GM-CSF in patients with advanced colorectal carcinoma: Long-lasting, complete remission can be induced. Int J Cancer 53:751, 1993